Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.51 USD | +11.32% | +7.11% | -14.45% |
07/05 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q1 Revenue $167.1M, vs. Street Est of $165.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.45% | 1.23B | |
+32.99% | 700B | |
-4.73% | 358B | |
+19.94% | 330B | |
+4.54% | 287B | |
+15.75% | 236B | |
+6.67% | 202B | |
-9.20% | 197B | |
+4.35% | 161B | |
-3.35% | 157B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Wedbush Trims Pacira BioSciences' Price Target to $94 From $97 on Zilretta 2022 Revenue Expectations; Outperform Rating Kept